chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: I could not breath after the shot later next day got better; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (I could not breath after the shot later next day got better) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031620A) for COVID-19 vaccination.     The patient's past medical history included Surgery. Concurrent medical conditions included Cancer. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), VITAMIN B COMPLEX, PANTOPRAZOLE, HCTZ, METOPROLOL, ATORVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ZINC and MAGNESIUM for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DYSPNOEA (I could not breath after the shot later next day got better). At the time of the report, DYSPNOEA (I could not breath after the shot later next day got better) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Fatigue, Limb discomfort, Nausea
Clinical narrative: very tired; sore arm; abdominal cramping; diarrhea; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (sore arm), ABDOMINAL PAIN (abdominal cramping), DIARRHOEA (diarrhea), NAUSEA (nausea) and VOMITING (vomiting) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no historical condition was reported).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced LIMB DISCOMFORT (sore arm), ABDOMINAL PAIN (abdominal cramping), DIARRHOEA (diarrhea), NAUSEA (nausea) and VOMITING (vomiting). On 06-Feb-2021, the patient experienced FATIGUE (very tired). At the time of the report, LIMB DISCOMFORT (sore arm), ABDOMINAL PAIN (abdominal cramping), DIARRHOEA (diarrhea), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-095359 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: very tired; sore arm; abdominal cramping; diarrhea; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (sore arm), ABDOMINAL PAIN (abdominal cramping), DIARRHOEA (diarrhea), NAUSEA (nausea) and VOMITING (vomiting) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no historical condition was reported).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced LIMB DISCOMFORT (sore arm), ABDOMINAL PAIN (abdominal cramping), DIARRHOEA (diarrhea), NAUSEA (nausea) and VOMITING (vomiting). On 06-Feb-2021, the patient experienced FATIGUE (very tired). At the time of the report, LIMB DISCOMFORT (sore arm), ABDOMINAL PAIN (abdominal cramping), DIARRHOEA (diarrhea), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-095359 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Arm where got vaccination is red; Arm where got vaccination blew up; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Arm where got vaccination is red) and VACCINATION SITE SWELLING (Arm where got vaccination blew up) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm where got vaccination is red) and VACCINATION SITE SWELLING (Arm where got vaccination blew up). At the time of the report, VACCINATION SITE ERYTHEMA (Arm where got vaccination is red) and VACCINATION SITE SWELLING (Arm where got vaccination blew up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not Applicable   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: follow up received on 28 April 2021, second dose received, no adverse events and no information on vaccine was provided.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Severe headaches and body aches; Severe headaches and body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Severe headaches and body aches) and HEADACHE (Severe headaches and body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Severe headaches and body aches) and HEADACHE (Severe headaches and body aches). At the time of the report, PAIN (Severe headaches and body aches) and HEADACHE (Severe headaches and body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Lip pruritus, Mouth ulceration, Rash, Rash pruritic
Clinical narrative: feels warm to the touch; rash and itch in the mouth; rash and itch in the lips; rash and itch around the face; Pink rash in her face and neck/ lip/ mouth; puffiness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (feels warm to the touch), MOUTH ULCERATION (rash and itch in the mouth), LIP PRURITUS (rash and itch in the lips), RASH PRURITIC (rash and itch around the face) and RASH (Pink rash in her face and neck/ lip/ mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (feels warm to the touch), MOUTH ULCERATION (rash and itch in the mouth), LIP PRURITUS (rash and itch in the lips), RASH PRURITIC (rash and itch around the face), RASH (Pink rash in her face and neck/ lip/ mouth) and SWELLING FACE (puffiness). At the time of the report, FEELING HOT (feels warm to the touch), MOUTH ULCERATION (rash and itch in the mouth), LIP PRURITUS (rash and itch in the lips), RASH PRURITIC (rash and itch around the face), RASH (Pink rash in her face and neck/ lip/ mouth) and SWELLING FACE (puffiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were  provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received and addition of new event puffiness..
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: feels warm to the touch; rash and itch in the mouth; rash and itch in the lips; rash and itch around the face; Pink rash in her face and neck/ lip/ mouth; puffiness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (feels warm to the touch), MOUTH ULCERATION (rash and itch in the mouth), LIP PRURITUS (rash and itch in the lips), RASH PRURITIC (rash and itch around the face) and RASH (Pink rash in her face and neck/ lip/ mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (feels warm to the touch), MOUTH ULCERATION (rash and itch in the mouth), LIP PRURITUS (rash and itch in the lips), RASH PRURITIC (rash and itch around the face), RASH (Pink rash in her face and neck/ lip/ mouth) and SWELLING FACE (puffiness). At the time of the report, FEELING HOT (feels warm to the touch), MOUTH ULCERATION (rash and itch in the mouth), LIP PRURITUS (rash and itch in the lips), RASH PRURITIC (rash and itch around the face), RASH (Pink rash in her face and neck/ lip/ mouth) and SWELLING FACE (puffiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were  provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received and addition of new event puffiness..
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disorientation, Myalgia, Pyrexia
Clinical narrative: Felt out of sorts; Body chills; Fever; Soreness in arms; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (Felt out of sorts), CHILLS (Body chills), PYREXIA (Fever) and MYALGIA (Soreness in arms) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISORIENTATION (Felt out of sorts), CHILLS (Body chills), PYREXIA (Fever) and MYALGIA (Soreness in arms). At the time of the report, DISORIENTATION (Felt out of sorts), CHILLS (Body chills), PYREXIA (Fever) and MYALGIA (Soreness in arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Lymphadenopathy, Nausea
Clinical narrative: 102 degree fever; lymph node swelling; Nausea; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (102 degree fever), LYMPHADENOPATHY (lymph node swelling), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PYREXIA (102 degree fever), LYMPHADENOPATHY (lymph node swelling), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headache). On 24-Feb-2021, PYREXIA (102 degree fever), LYMPHADENOPATHY (lymph node swelling), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, Body temperature: 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 102 degree fever; lymph node swelling; Nausea; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (102 degree fever), LYMPHADENOPATHY (lymph node swelling), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PYREXIA (102 degree fever), LYMPHADENOPATHY (lymph node swelling), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headache). On 24-Feb-2021, PYREXIA (102 degree fever), LYMPHADENOPATHY (lymph node swelling), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, Body temperature: 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Back injury, Fall, Headache, Sinusitis
Clinical narrative: fall; injured her back; headache that won't go away; Sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection), FALL (fall) and BACK INJURY (injured her back) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported). Concomitant products included PARACETAMOL (TYLENOL).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced SINUSITIS (Sinus infection) with HEADACHE (headache that won't go away). On an unknown date, the patient experienced FALL (fall) and BACK INJURY (injured her back). At the time of the report, SINUSITIS (Sinus infection), FALL (fall) and BACK INJURY (injured her back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reaction). At the time of the report, VACCINATION COMPLICATION (adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow up was received on 27-APR-2021 and contact information was updated.
Sex: F
Vaccine: COVID19
Symptoms: Back injury
Clinical narrative: twisted back in a wrong way; This spontaneous case was reported by a consumer and describes the occurrence of BACK INJURY (twisted back in a wrong way) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced BACK INJURY (twisted back in a wrong way). At the time of the report, BACK INJURY (twisted back in a wrong way) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: abrupt dizziness; light headed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (abrupt dizziness) and DIZZINESS (light headed) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced DIZZINESS (abrupt dizziness) and DIZZINESS (light headed). At the time of the report, DIZZINESS (abrupt dizziness) and DIZZINESS (light headed) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications have not been reported.  Treatment has not been specified.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Splitting headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Splitting headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced HEADACHE (Splitting headache). At the time of the report, HEADACHE (Splitting headache) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not reported.  Treatment details included Aleve.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Cheilitis
Clinical narrative: expansion of lips; rash around lips; This spontaneous case was reported by a consumer and describes the occurrence of CHEILITIS (expansion of lips) and CHEILITIS (rash around lips) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D), LISINOPRIL, HYDROXYZINE EMBONATE (VISTARIL [HYDROXYZINE EMBONATE]), OXYBUTYNIN, PROBIOTIC 10, TEMAZEPAM, CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]), MULTIVITAMIN & MINERAL, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), DONEPEZIL HCL and CEFTRIAXONE SODIUM, TAZOBACTAM SODIUM (BACTRUM T) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced CHEILITIS (expansion of lips) and CHEILITIS (rash around lips). On 09-Feb-2021, CHEILITIS (expansion of lips) had resolved. At the time of the report, CHEILITIS (rash around lips) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Benadryl (diphenhydramine), Benadryl cream, hydrocortisone cream, vasoline petrolium jelly.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Erythema, Oral discomfort
Clinical narrative: lips burning; red face; increased blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of ORAL DISCOMFORT (lips burning), ERYTHEMA (red face) and BLOOD PRESSURE INCREASED (increased blood pressure) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.  On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ORAL DISCOMFORT (lips burning), ERYTHEMA (red face) and BLOOD PRESSURE INCREASED (increased blood pressure). On 24-Feb-2021, ERYTHEMA (red face) and BLOOD PRESSURE INCREASED (increased blood pressure) had resolved. At the time of the report, ORAL DISCOMFORT (lips burning) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Rash pruritic
Clinical narrative: itchy rash; red arm; swollen arm; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (swollen arm), RASH PRURITIC (itchy rash) and ERYTHEMA (red arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included SIMVASTATIN and LOSARTAN POTASSIUM for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and ERYTHEMA (red arm). On 23-Feb-2021, the patient experienced RASH PRURITIC (itchy rash). On 15-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, PERIPHERAL SWELLING (swollen arm), RASH PRURITIC (itchy rash) and ERYTHEMA (red arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Benadryl (diphenhydramine) and cortisone cream.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea
Clinical narrative: throat hurting a little like soreness / Sore throat; sniffles; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (sniffles) and OROPHARYNGEAL PAIN (throat hurting a little like soreness / Sore throat) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No medical history reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced RHINORRHOEA (sniffles). On 08-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (throat hurting a little like soreness / Sore throat). On 07-Feb-2021, RHINORRHOEA (sniffles) had resolved. At the time of the report, OROPHARYNGEAL PAIN (throat hurting a little like soreness / Sore throat) outcome was unknown. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: No specific follow-up information recorded.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Limb discomfort, Pyrexia
Clinical narrative: Fever; Fatigue; Headache; Fatigue; Discomfort in the arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), the first episode of FATIGUE (Fatigue), LIMB DISCOMFORT (Discomfort in the arm), PYREXIA (Fever) and the second episode of FATIGUE (Fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and UKNOWN) for COVID-19 vaccination.     No medical history reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced HEADACHE (Headache), the first episode of FATIGUE (Fatigue) and LIMB DISCOMFORT (Discomfort in the arm). On 22-Feb-2021, the patient experienced PYREXIA (Fever) and the second episode of FATIGUE (Fatigue). On 22-Feb-2021, PYREXIA (Fever) had resolved. At the time of the report, HEADACHE (Headache), LIMB DISCOMFORT (Discomfort in the arm) and the last episode of FATIGUE (Fatigue) outcome was unknown.      No relevant concomitant medications were reported.  Treatment details not included.   This case was linked to MOD-2021-023100 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: pain in the leg muscle (back of the leg) Pain was described as electric shock; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pain in the leg muscle (back of the leg) Pain was described as electric shock) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 041L204) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol, Prostate cancer and Indigestion. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (pain in the leg muscle (back of the leg) Pain was described as electric shock). At the time of the report, MYALGIA (pain in the leg muscle (back of the leg) Pain was described as electric shock) outcome was unknown.     Concomitant product use included cholesterol medicine, prostate cancer medicine and indigestion medicine. The patient did not take anything to treat symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Additional information received captured reporter contact details.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: a little soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little soreness in the arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included ESOMEPRAZOLE, CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and LEVOTHYROXINE for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (a little soreness in the arm). The patient was treated with PARACETAMOL for Pain in extremity, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (a little soreness in the arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-053231 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Decreased appetite, Feeling abnormal, Headache, Myalgia
Clinical narrative: Her eyes were sensitive to the light; they don't feel right; nausea again; it was the worst day; a very bad nausea; Splitting headache; Backache; Muscle ache; Didn't have any appetite; she began with symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (a very bad nausea), HEADACHE (Splitting headache), BACK PAIN (Backache), MYALGIA (Muscle ache) and DECREASED APPETITE (Didn't have any appetite) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Polymyalgia rheumatica and Sjogren's. Concomitant products included HYDROXYCHLOROQUINE, VALSARTAN, HYDROCHLOROTHIAZIDE and FAMOTIDINE for an unknown indication.  On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION COMPLICATION (she began with symptoms). On 20-Feb-2021, the patient experienced NAUSEA (a very bad nausea), HEADACHE (Splitting headache), BACK PAIN (Backache), MYALGIA (Muscle ache), DECREASED APPETITE (Didn't have any appetite) and FEELING ABNORMAL (it was the worst day). On 23-Feb-2021, the patient experienced PHOTOPHOBIA (Her eyes were sensitive to the light), FEELING ABNORMAL (they don't feel right) and NAUSEA (nausea again). On 22-Feb-2021, NAUSEA (a very bad nausea), HEADACHE (Splitting headache), BACK PAIN (Backache), MYALGIA (Muscle ache) and DECREASED APPETITE (Didn't have any appetite) had resolved. At the time of the report, PHOTOPHOBIA (Her eyes were sensitive to the light), FEELING ABNORMAL (they don't feel right), VACCINATION COMPLICATION (she began with symptoms), FEELING ABNORMAL (it was the worst day) and NAUSEA (nausea again) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Excedrin: Aspirin /Paracetamol /Caffeine.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Photophobia, Vaccination complication
Clinical narrative: Her eyes were sensitive to the light; they don't feel right; nausea again; it was the worst day; a very bad nausea; Splitting headache; Backache; Muscle ache; Didn't have any appetite; she began with symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (a very bad nausea), HEADACHE (Splitting headache), BACK PAIN (Backache), MYALGIA (Muscle ache) and DECREASED APPETITE (Didn't have any appetite) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Polymyalgia rheumatica and Sjogren's. Concomitant products included HYDROXYCHLOROQUINE, VALSARTAN, HYDROCHLOROTHIAZIDE and FAMOTIDINE for an unknown indication.  On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION COMPLICATION (she began with symptoms). On 20-Feb-2021, the patient experienced NAUSEA (a very bad nausea), HEADACHE (Splitting headache), BACK PAIN (Backache), MYALGIA (Muscle ache), DECREASED APPETITE (Didn't have any appetite) and FEELING ABNORMAL (it was the worst day). On 23-Feb-2021, the patient experienced PHOTOPHOBIA (Her eyes were sensitive to the light), FEELING ABNORMAL (they don't feel right) and NAUSEA (nausea again). On 22-Feb-2021, NAUSEA (a very bad nausea), HEADACHE (Splitting headache), BACK PAIN (Backache), MYALGIA (Muscle ache) and DECREASED APPETITE (Didn't have any appetite) had resolved. At the time of the report, PHOTOPHOBIA (Her eyes were sensitive to the light), FEELING ABNORMAL (they don't feel right), VACCINATION COMPLICATION (she began with symptoms), FEELING ABNORMAL (it was the worst day) and NAUSEA (nausea again) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Excedrin: Aspirin /Paracetamol /Caffeine.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Headache; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No medical history reported.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown.      No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Limb discomfort, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Really bad stabbing pain in her collar bone; Injection site was a little red, swollen and hurt a bit; Injection site was a little red, swollen and hurt a bit; Arm was really bothering her; Injection site was a little red, swollen and hurt a bit; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Really bad stabbing pain in her collar bone), VACCINATION SITE ERYTHEMA (Injection site was a little red, swollen and hurt a bit), VACCINATION SITE SWELLING (Injection site was a little red, swollen and hurt a bit), LIMB DISCOMFORT (Arm was really bothering her) and VACCINATION SITE PAIN (Injection site was a little red, swollen and hurt a bit) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced BONE PAIN (Really bad stabbing pain in her collar bone), VACCINATION SITE ERYTHEMA (Injection site was a little red, swollen and hurt a bit), VACCINATION SITE SWELLING (Injection site was a little red, swollen and hurt a bit), LIMB DISCOMFORT (Arm was really bothering her) and VACCINATION SITE PAIN (Injection site was a little red, swollen and hurt a bit). The patient was treated with PARACETAMOL (TYLENOL) on 30-Jan-2021 for Limb discomfort, at an unspecified dose and frequency. On 31-Jan-2021, BONE PAIN (Really bad stabbing pain in her collar bone), VACCINATION SITE ERYTHEMA (Injection site was a little red, swollen and hurt a bit), VACCINATION SITE SWELLING (Injection site was a little red, swollen and hurt a bit), LIMB DISCOMFORT (Arm was really bothering her) and VACCINATION SITE PAIN (Injection site was a little red, swollen and hurt a bit) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pruritus, Urticaria
Clinical narrative: Hives on one side of her stomach; Itchy; The injection site was a red rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on one side of her stomach), PRURITUS (Itchy) and INJECTION SITE RASH (The injection site was a red rash) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A.) for COVID-19 vaccination.     No medical history reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced PRURITUS (Itchy) and INJECTION SITE RASH (The injection site was a red rash). On 22-Feb-2021, the patient experienced URTICARIA (Hives on one side of her stomach). On 18-Feb-2021, PRURITUS (Itchy) and INJECTION SITE RASH (The injection site was a red rash) had resolved. At the time of the report, URTICARIA (Hives on one side of her stomach) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site joint swelling, Tinnitus
Clinical narrative: intermittent ringing of the ears; mild arm soreness; Tiredness; headache; This spontaneous case was reported by a nurse and describes the occurrence of INJECTION SITE JOINT SWELLING (mild arm soreness), TINNITUS (intermittent ringing of the ears), FATIGUE (Tiredness) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039k202a and 007m20a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PANTOPRAZOLE, LEVOTHYROXINE, BUPROPION, MULTIVITAMIN & MINERAL, CALCIUM and VITAMIN D3 for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE JOINT SWELLING (mild arm soreness), TINNITUS (intermittent ringing of the ears), FATIGUE (Tiredness) and HEADACHE (headache). At the time of the report, INJECTION SITE JOINT SWELLING (mild arm soreness), TINNITUS (intermittent ringing of the ears), FATIGUE (Tiredness) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment information includes Z-park
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasal congestion, Oropharyngeal pain, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Congestion; Sore throat; Fatigue; Heat at the site of injection; Redness at the site of injection; swelling at the site of injection; Itchiness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Heat at the site of injection), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE SWELLING (swelling at the site of injection) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included PROGESTERONE, TRAZODONE and AZELASTINE for an unknown indication.  On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Heat at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection) and VACCINATION SITE PRURITUS (Itchiness at the site of injection). On 21-Feb-2021, the patient experienced FATIGUE (Fatigue). On 24-Feb-2021, the patient experienced NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (Sore throat). On 23-Feb-2021, FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE WARMTH (Heat at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection) and VACCINATION SITE PRURITUS (Itchiness at the site of injection) had not resolved and NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Nyquil (doxylamin-PSE-DM-acetaminophen),  Daiquil (Acetaminophen, Dextromethorphan, and Pseudoephedrin), anti itch cream with lidocaine, moisturizer, aloe vera.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Congestion; Sore throat; Fatigue; Heat at the site of injection; Redness at the site of injection; swelling at the site of injection; Itchiness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Heat at the site of injection), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE SWELLING (swelling at the site of injection) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included PROGESTERONE, TRAZODONE and AZELASTINE for an unknown indication.  On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Heat at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection) and VACCINATION SITE PRURITUS (Itchiness at the site of injection). On 21-Feb-2021, the patient experienced FATIGUE (Fatigue). On 24-Feb-2021, the patient experienced NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (Sore throat). On 23-Feb-2021, FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE WARMTH (Heat at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection) and VACCINATION SITE PRURITUS (Itchiness at the site of injection) had not resolved and NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Nyquil (doxylamin-PSE-DM-acetaminophen),  Daiquil (Acetaminophen, Dextromethorphan, and Pseudoephedrin), anti itch cream with lidocaine, moisturizer, aloe vera.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tiredness he had to go to bed; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness he had to go to bed) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L2OA) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol.  On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced FATIGUE (Tiredness he had to go to bed). On 08-Feb-2021, FATIGUE (Tiredness he had to go to bed) had resolved. Not applicable    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications included Cholesterol medication and Blood pressure medication (Unspecified).  Treatment details was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Influenza like illness, Pain, Pain in extremity
Clinical narrative: Felt like I had the flu; Pressure In Head; Sore arm; Aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like I had the flu), HEAD DISCOMFORT (Pressure In Head), PAIN IN EXTREMITY (Sore arm) and PAIN (Aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder. Concomitant products included AMLODIPINE for an unknown indication.  On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like I had the flu), HEAD DISCOMFORT (Pressure In Head), PAIN IN EXTREMITY (Sore arm) and PAIN (Aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Flu-like symptoms, at an unspecified dose and frequency. In February 2021, INFLUENZA LIKE ILLNESS (Felt like I had the flu), HEAD DISCOMFORT (Pressure In Head), PAIN IN EXTREMITY (Sore arm) and PAIN (Aches) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Type IV hypersensitivity reaction
Clinical narrative: Soreness of the arm; COVID arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Feb-2021 and was forwarded to Moderna on 07-Feb-2021.    This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Soreness of the arm) and TYPE IV HYPERSENSITIVITY REACTION (COVID arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness of the arm) and TYPE IV HYPERSENSITIVITY REACTION (COVID arm). At the time of the report, PAIN IN EXTREMITY (Soreness of the arm) and TYPE IV HYPERSENSITIVITY REACTION (COVID arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow up report was possible NNI.